Expanding the repertoire of RNA interference screens for developing new anticancer drug targets

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.11, Iss.11, 2007-11, pp. : 1429-1441

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RNA-Mediated Interference as a Tool for Identifying Drug Targets

By Oneil N.J. Martin R.L. Tomlinson M.L. Jones M.R. Coulson A. Kuwabara P.E.

American Journal of PharmacoGenomics, Vol. 1, Iss. 1, 2001-01 ,pp. : 45-53

Adis International

Access to resources Recommend Favorite

Helicases as Antiviral and Anticancer Drug Targets

Current Medicinal Chemistry, Vol. 14, Iss. 8, 2007-04 ,pp. : 883-915

Bentham Science Publishers

Access to resources Recommend Favorite

Current Targets for Anticancer Drug Discovery

Current Drug Targets, Vol. 4, Iss. 2, 2003-02 ,pp. : 159-179

Bentham Science Publishers

Access to resources Recommend Favorite

RNA Interference-Mediated Validation of Survivin and Apollon/BRUCE as New Therapeutic Targets for Cancer Therapy

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 2, 2012-01 ,pp. : 69-78

Bentham Science Publishers

Access to resources Recommend Favorite

Thalidomide: a new anticancer drug?

By Fanelli Massimo Sarmiento Roberta Gattuso Domenico Carillio Guido Capaccetti Barbara Vacca Angelo Roccaro Aldo Maria Gasparini Giampietro

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 7, 2003-07 ,pp. : 1211-1225

Informa Healthcare

Access to resources Recommend Favorite